Labarium

Established by leading executives and innovators in the field of molecular laboratories and personalized medicine, Labarium seeks to grow through strategic acquisitions of high-performing, compliant clinical laboratories across the United States to deliver its proprietary platforms to improve healthcare decisions. Though the company acquires and operates clinical laboratories, Labarium understands that it is an information company advancing healthcare to become more predictive and personalized. To do this, Labarium provides intelligent diagnostic, prognostic, and treatment-defining information from its laboratories that turn "commodity" lab testing into more meaningful and actionable information to improve up to 80% of medical decisions informed by laboratory tests. By improving these healthcare decisions, Labarium supports better and more personalized care, lower costs, better outcomes, superior research, more targeted treatments, and reduced risk.